Safety study of DF5112 in healthy adults
This study tests a new drug called DF5112 in healthy adults to find the safest dose. It helps doctors learn how the drug works in the body before testing it in people with a condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You are generally healthy, with no major medical conditions.
- You haven't had cancer in the last 5 years (except some skin cancers or cervical polyps).
- You do not have active or chronic infections, including hepatitis, HIV, or tuberculosis.
- You haven't had a vaccine in the last month and aren't planning one soon.
- You are not pregnant, nursing, or planning pregnancy during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called PF-07985631 in healthy adults to see how different amounts are tolerated and processed by the body. It includes specific groups for Japanese and Chinese participants.
This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.
This early-phase study tests a new experimental drug (M5542) in healthy volunteers to see how safe it is and how the body processes a single dose. If you are in good health and meet simple weight and medical history criteria, you may be able to join.
This early-stage study tests a new investigational drug (called WD-910) in healthy volunteers to see how safe it is, how the body processes it, and how it affects the body. You would receive either the drug or a placebo (a pill with no active medicine), and doctors will monitor you closely.
This study tests a new investigational drug (DA-5222) in healthy volunteers to see how food affects its absorption. It helps determine the best way to take the medication.
This trial tests the safety of a new drug called KT-579 in healthy adults. It is the first time this drug is being given to humans. The study will help doctors understand how the drug works in the body and if it is safe.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.